Quick look:
FY revenue of $24.3m; includes $2.9m from the Custom Pack business. H1 had a revenue of $10.151M, plus $2.9m from the Custom Pack business. So H2 delivering an increase in revenue of $1M.
EBITDA for the Group of $3.5m after the funding of MyHealthTest’s further development.
Does this figure include the profits of the sale of the Custom Pack business, which is $8.6M? If it does I would dare say it's a disappointing result.
ITD Price at posting:
17.5¢ Sentiment: None Disclosure: Held
